Evidence map›Paper›PMID 35177580›Full record

ArticleAnnals of transplantation2022

Impact on Waitlist Outcomes from Changes in the Medical Eligibility of Candidates for Simultaneous Liver-Kidney Transplantation Following Implementation of the 2017 Organ Procurement and Transplantation Network/United Network for Organ Sharing Policy in the United States.

Shingo Shimada, Toshihiro Kitajima, Yukiko Suzuki, Yasutaka Kuno, Tayseer Shamaa, Tommy Ivanics, Kelly Collins, Michael Rizzari, Atsushi Yoshida, Marwan Abouljoud and 2 more

Abstract read
In one paragraph

Article in Annals of transplantation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Exploring Disease-Specific Waitlist Outcomes in Simultaneous Liver-Kidney Transplantation.Transplant international : official journal of the European Society for Organ Transplantation · 2026
    Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Shingo ShimadaDivision of Transplant and Hepatobiliary Surgery, Henry Ford Hospital, Detroit, MI, USA.
Toshihiro KitajimaDivision of Transplant and Hepatobiliary Surgery, Henry Ford Hospital, Detroit, MI, USA.
Yukiko SuzukiDivision of Transplant and Hepatobiliary Surgery, Henry Ford Hospital, Detroit, MI, USA.
Yasutaka KunoDivision of Transplant and Hepatobiliary Surgery, Henry Ford Hospital, Detroit, MI, USA.
Tayseer ShamaaDivision of Transplant and Hepatobiliary Surgery, Henry Ford Hospital, Detroit, MI, USA.
Tommy IvanicsDivision of Transplant and Hepatobiliary Surgery, Henry Ford Hospital, Detroit, MI, USA.ORCID 0000-0002-1312-4470
Kelly CollinsDivision of Transplant and Hepatobiliary Surgery, Henry Ford Hospital, Detroit, MI, USA.
Michael RizzariDivision of Transplant and Hepatobiliary Surgery, Henry Ford Hospital, Detroit, MI, USA.
Atsushi YoshidaDivision of Transplant and Hepatobiliary Surgery, Henry Ford Hospital, Detroit, MI, USA.
Marwan AbouljoudDivision of Transplant and Hepatobiliary Surgery, Henry Ford Hospital, Detroit, MI, USA.
Dilip MoonkaDivision of Gastroenterology and Hepatology, Henry Ford Hospital, Detroit, MI, USA.
Shunji NagaiDivision of Transplant and Hepatobiliary Surgery, Henry Ford Hospital, Detroit, MI, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND The new simultaneous liver-kidney transplantation (SLK) listing criteria in the United States was implemented in 2017. We aimed to investigate the impact on waitlist and post-transplantation outcomes from changes in the medical eligibility of candidates for SLK after policy implementation in the United States. MATERIAL AND METHODS We analyzed adult primary SLK candidates between January 2015 and March 2019 using the Organ Procurement and Transplant Network/United Network for Organ Sharing (OPTN/UNOS) registry. We compared waitlist practice, post-transplantation outcomes, and final transplant graft type in SLK candidates before and after the policy. RESULTS A total of 4641 patients were eligible, with 2975 and 1666 registered before and after the 2017 policy, respectively. The daily number of SLK candidates was lower after the 2017 policy (3.25 vs 2.89, P=0.01); 1956 received SLK and 95 received liver transplant alone (LTA). The proportion of patients who eventually received LTA was higher after the 2017 policy (7.9% vs 3.0%; P<0.001). The 1-year graft survival rate was worse in patients with LTA than in those with SLK (80.5% vs 90.4%; P=0.003). The adjusted risk of 1-year graft failure in patients with LTA was 2.01 (95% confidence interval 1.13-3.58, P=0.01) compared with patients with SLK among the SLK candidates. CONCLUSIONS Although the number of registrations for SLK increased, the number of SLK transplants decreased, and the number of liver transplants increased. LTA in this patient cohort was associated with worse post-transplantation outcomes.

Indexed as

Kidney TransplantationLiver TransplantationTissue and Organ ProcurementAdultHumansLiverPolicyRisk FactorsUnited States

Identifiers

PMID35177580
PMCPMC8876003

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.